top of page

Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB


Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...


Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...


The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
AbbVie Acquires Gilgamesh’s $1.2B Psychedelic Antidepressant Program to Tackle Major Depression
North Chicago, IL and New York, August 25, 2025 ( PRNewswire ) -- AbbVie will acquire Gilgamesh’s bretisilocin program for up to $1.2...
Galvanize Secures $100M Series C and Appoints Doug Godshall as CEO to Advance PEF Therapies
Redwood City, CA, September 3, 2025 (PRNewswire) -- Galvanize Therapeutics closed an oversubscribed $100 million Series C round led by...
Novartis Bets $1.4B on Inflammation Pathway With Tourmaline Bio Acquisition
Basel, September 9, 2025 (Novartis) -- Novartis will acquire Tourmaline Bio for $1.4 billion, adding pacibekitug—an anti-IL-6 antibody...
Gilead’s Kite Acquires Interius for $350M to Advance In Vivo CAR T-Cell Therapy Platform
Foster City, CA, August 21, 2025 (Reuters) -- Kite Pharma, a Gilead subsidiary, will acquire Interius BioTherapeutics for $350 million...
Bioretec Names Sarah van Hellenberg Hubar-Fisher as CEO to Drive Global Growth in Absorbable Orthopedic Implants
Tampere, Finland, August 27, 2025 (PRNewswire) -- Bioretec Ltd. has appointed Sarah van Hellenberg Hubar-Fisher as Chief Executive...
AbbVie Acquires Gilgamesh’s $1.2B Psychedelic Depression Therapy, Expanding Psychiatry Portfolio
North Chicago, IL and New York, August 25, 2025 (PRNewswire) -- AbbVie will acquire Gilgamesh Pharmaceuticals’ bretisilocin program for...
Zynex Announces New CEO Steven Dyson and Expanded Leadership Team to Drive Growth and Innovation
Englewood, CO, August 18, 2025 (PRNewswire) -- Zynex has appointed Steven Dyson as CEO and filled several critical executive roles to...
Terumo Acquires OrganOx for $1.5B, Expanding into Organ Transplantation with Advanced Preservation Technology
Oxford, UK and Madison, NJ, August 24, 2025 (Globe Newswire) -- Terumo Corporation will acquire OrganOx Limited for approximately $1.5...
Apreo Health Secures $130M to Propel BREATHE Implant Toward Pivotal Emphysema Trial
California, August 7, 2025 (Yahoofinance) -- California-based startup Apreo Health has secured $130 million in a Series B funding round...
Thomas Moore Named CEO of Minze Health
Belgium & Minneapolis, August 12, 2025 (Business Wire) -- Minze Health, a digital diagnostics and therapeutics company focused on...
HistoSonics, Backed by Bezos Expeditions, Achieves $2.25B Valuation in Management-Led Deal
Minneapolis, August 7, 2025 (Business Wire) -- HistoSonics, developer of the Edison® Histotripsy System, has completed a management-led...
Vicarious Surgical Taps Stephen From as CEO
Waltham, MA, August 7, 2025 (Business Wire) -- Vicarious Surgical Inc., a next-generation robotics company aiming to transform surgical...
bottom of page

